Skip to main content
  • Home
  • Drug Formulation (DFM)
  • Drug Inactive Ingredient (DIG)
  • Biological Target of DIG (DBT)
  • Download
  • ?

Drug Information

Drug General Information
Drug ID
D09JAK
Drug Name
3052230
Synonyms
3052230
Indication Unspecified Investigative [1559364]
Target and Pathway
Target(s) Basic fibroblast growth factor receptor 1 Target Info Modulator
KEGG Pathway MAPK signaling pathway
Ras signaling pathway
Rap1 signaling pathway
PI3K-Akt signaling pathway
Adherens junction
Signaling pathways regulating pluripotency of stem cells
Regulation of actin cytoskeleton
Pathways in cancer
Proteoglycans in cancer
Prostate cancer
Melanoma
Central carbon metabolism in cancer
NetPath Pathway TCR Signaling Pathway
PANTHER Pathway Angiogenesis
FGF signaling pathway
Pathway Interaction Database Glypican 1 network
Syndecan-4-mediated signaling events
N-cadherin signaling events
FGF signaling pathway
WikiPathways Regulation of Actin Cytoskeleton
Endochondral Ossification
MAPK Signaling Pathway
Mesodermal Commitment Pathway
Hair Follicle Development: Induction (Part 1 of 3)
Integrated Pancreatic Cancer Pathway
Signaling Pathways in Glioblastoma
Neural Crest Differentiation
Signaling by FGFR
References
Ref 1559364Company report (Fiveprime)

If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.

Cite ACDINA

C. Y. Zhang, M. J. Mou, Y. Zhou, W. Zhang, X. C. Lian, S. Y. Shi, M. K. Lu, H. C. Sun, F. C. Li, Y. X. Wang, Z. Y. Zeng, Z. R. Li, B. Zhang, Y. Q. Qiu, F. Zhu* & J. Q. Gao*. Biological activities of drug inactive ingredients. Briefings in Bioinformatics. 23(5): bbac160 (2022). PMID: 35524477

About ACDINA

A database (1) describing the largest number of well-defined DIGs and drug formulations, (2) providing the comprehensive biological activity data for both DIGs and drug formulations, and (3) fully referencing the biological targets by cross-linking them to available databases that describe their pharmaceutical/biological characteristics.

All rights are reserved.

Correspondence

Prof. Feng ZHU 

Lab of Innovative Drug Research and Bioinformatics


Prof. Jianqing GAO 

Lab of Biotechnology Pharmaceutics


College of Pharmaceutical Sciences,

Zhejiang University, China